Company Spotlight: St. Jude Medical

  • Follow Business

ST. JUDE MEDICAL

Shares of St. Jude Medi­cal rose after the device maker received European approval to sell the first pacemaker that doesn’t require implanted wires to attach to the heart.

The device was developed by California-based startup Nanostim with funding from St. Jude. The St. Paul, Minn.-based device maker also said it would acquire the smaller company for more than $123 million.

Pacemakers are battery-powered implants that help the heart maintain a steady beat. The devices have traditionally been implanted through a surgery that creates a small pocket in the chest for the device and its wires, called leads, which attach to the heart.

The Nanostim pacemaker’s battery is designed to last between nine and 13 years. It is expected to soon launch in some European countries.

THE STOCK

St. Jude Medical (STJ)

Monday’s close: 56.03, ▲ 0.87, or 1.58%

52-week range: $30-$57

Annual dividend: $1

Dividend yield: 1.8%

Price-earnings ratio *: 26

Total return YTD: 58%

3-year **: 14%

10-year **: 8%

Note: Total returns through Oct.14

* Trailing 12 months; ** Annualized

Source: FactSet, Associated Press


Top headlines

Commission rejects tax jump

Seven commissioners nixed a proposed tax increase Monday that would cost a typical homeowner $70 a year, leaving the countywide millage unset with just a few days to meet state deadlines.
Search Augusta jobs